However, one of the challenges with identifying retinoblastomas driven exclusively by MYCN amplification is excluding all possible mechanisms of RB1 gene inactivation including SNVs, indels, LOH, deletions, translocations and promoter hypermethylation. The gene discussed is RB1; the disease is retinoblastoma.